COWEN AND COMPANY, LLC - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217125. A total of 50 filers reported holding BIOPLUS ACQUISITION CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
COWEN AND COMPANY, LLC ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q3 2023$29,237
-57.0%
522,096
+13.3%
0.00%
-66.7%
Q2 2023$67,949
+412.0%
460,987
+230.0%
0.01%
+200.0%
Q1 2023$13,271
-25.3%
139,700
-21.4%
0.00%0.0%
Q4 2022$17,766
+48.0%
177,845
+18.6%
0.00%
+100.0%
Q3 2022$12,000
-42.9%
149,950
+0.1%
0.00%
-50.0%
Q2 2022$21,000
-4.5%
149,850
+58.1%
0.00%0.0%
Q1 2022$22,00094,7850.00%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q3 2023
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 369,289$3,774,1340.21%
Radcliffe Capital Management, L.P. 200,049$2,052,5030.06%
LMR Partners LLP 125,000$1,277,5000.02%
Q Global Advisors, LLC 195,489$200.01%
MARSHALL WACE, LLP 190,150$1,954,7430.00%
MMCAP International Inc. SPC 325,000$32,4680.00%
PERISCOPE CAPITAL INC. 867,072$37,1400.00%
COWEN AND COMPANY, LLC 177,845$17,7660.00%
CANTOR FITZGERALD, L. P. 250,000$250.00%
EHP Funds Inc. 125,186$60.00%
View complete list of BIOPLUS ACQUISITION CORP shareholders